Posted on 2/22/21
What Should Vertex Pharmaceuticals Buy With its $6.6 Billion Stash?
Vertex Pharmaceuticals (NASDAQ:VRTX) has $6.6 billion in the bank and continues to generate more cash flow each quarter. While Vertex has some early stage drugs that . . .
Posted on 2/22/21
Is Moderna Stock a Buy?
Few companies can legitimately claim to have made a profound impact on human history. Moderna (NASDAQ:MRNA) is arguably an exception. The biotech's rapid development of a . . .
Posted on 2/21/21
Citius Pharmaceuticals Closes $76.5M Registered Direct Offering
Citius Pharmaceuticals, Inc. (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, today announced that it has closed its previously . . .
Posted on 2/21/21
Maryland Administers More Than 1M Vaccine Doses, Fully Vaccinates About 5% of Residents
Maryland has administered 1,013,049 vaccine doses to date, and about 5% of the state’s residents have received two doses of the vaccine as of Friday morning.The . . .
Posted on 2/21/21
Broward Health Foundation's Tribute to Healthcare Heroes Raises More Than $225,000 for Covid-19 Relief Fund
Broward Health Foundation recently hosted its Tribute to Healthcare Heroes presented by Skanska, an inspiring virtual presentation that honored Broward Health’s selfless healthcare workers during a . . .
Posted on 2/19/21
AIkido Pharma Closes of $75 Million Bought Deal Offering of Common Stock
AIkido Pharma Inc. (Nasdaq: AIKI) today announced the closing of its previously announced underwritten public offering of 46,875,000 shares of its common stock at a price . . .
Posted on 2/19/21
AmerisourceBergen Named Best Place to Work for LGBTQ Equality
VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen, a global healthcare company, proudly announced that it received a perfect score of 100 on the 2021 Corporate Equality Index (CEI), the . . .
Posted on 2/19/21
Ayala Pharmaceuticals Announces $25 Million Strategic Financing
Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, today . . .
Posted on 2/19/21
U.Va. Health System to Acquire Novant Health
The University of Virginia Health System has signed a letter of intent to buy out Novant Health U.Va. Health System, a Northern Virginia regional health system . . .
Posted on 2/19/21
Is Novavax Stock a Good Bet on Coronavirus Vaccines?
If you look only at Novavax's (NASDAQ:NVAX) share performance last year, you would probably hesitate to buy the stock today. The biotech company soared more than . . .
Posted on 2/19/21
Pfizer and BioNTech Launch Coronavirus Vaccine Study for Pregnant Women
With their BNT162b2 coronavirus vaccine now being distributed in major markets to inoculate the general public, Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) have moved to test it . . .
Posted on 2/19/21
State Roundup: Senate Democratic Leaders Introduce COVID Policy Package
SENATE DEM LEADERS INTRODUCE COVID POLICY PACKAGE: Senate Democratic leaders Wednesday outlined the framework of a legislative package aimed at addressing a myriad of challenges associated . . .
Posted on 2/19/21
Bio-Path Holdings Closes $13.0 Million Public Offering of Common Stock
HOUSTON, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (Nasdaq:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a . . .
Posted on 2/19/21
Medicus Sciences Acquisition Corp. Closes $92M IPO
Medicus Sciences Acquisition Corp. announced today the closing of its initial public offering of 9,200,000 units, which included the full exercise of the underwriter's over-allotment option to . . .
Posted on 2/18/21
Maryland’s Coronavirus Hospitalizations Decrease for 10 Straight Days
The number of Marylanders hospitalized due to coronavirus has decreased for 10 consecutive days, reaching 1,048 hospitalizations on Thursday.Of those currently hospitalized, 769 are in acute . . .
Posted on 2/18/21
Thermo Fisher Scientific Recognized with Six CMO Leadership Awards
Thermo Fisher Scientific, the world leader in serving science, today announced it has won six awards in the annual CMO Leadership Awards. The awards, presented by . . .
Posted on 2/18/21
LabCentral Announces $22.4 Million in Committed Funding for LabCentral 238
LabCentral, the first-of-its-kind shared laboratory space designed as a launchpad for high-potential biotech startups, today announced a total of $22.4 million in sponsorship commitments for LabCentral . . .
Posted on 2/18/21
Phio Pharmaceuticals Closes of $7.7 Million Registered Direct Offering of Common Stock
Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL) therapeutic platform, today announced . . .
Posted on 2/18/21
Talk To Your Doc About Cancer Screenings!
In conjunction with National Cancer Prevention Month this February and with declines in cancer screenings during
Posted on 2/18/21
IQVIA Prices of Offering of Senior Notes
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc., priced an offering of €1,450,000,000 . . .
Posted on 2/18/21
Infinity Closes of $92 Million Public Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (Nasdaq: INFI), a clinical-stage biotechnology company developing eganelisib, a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which addresses a fundamental biologic . . .
Posted on 2/18/21
‘COVID-19 Business School’ from Virtual Is Now Accepting All Students
Virtual, Inc. opened the doors to CEO Andy Freed's COVID-19 Business School,’ a master class to be held online today at 2 p.m. Eastern. Interested students . . .
Posted on 2/18/21
Arch Therapeutics Closes of $6.9 Million Private Placement
FRAMINGHAM, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH), developer of novel self-assembling wound care and biosurgical devices, today announced it has . . .
Posted on 2/18/21
Molecular Templates Prices of $75.9 Million Public Equity Offering
AUSTIN, Texas, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM), a clinical-stage biopharmaceutical company focused on the discovery and development of the Company’s . . .
Posted on 2/18/21
Molecular Templates Prices of $75.9 Million Public Equity Offering
AUSTIN, Texas, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM), a clinical-stage biopharmaceutical company focused on the discovery and development of the Company’s . . .
